Approaches of marine compounds and relevant immune mediators in Autism Spectrum Disorder: Opportunities and challenges

Eur J Med Chem. 2024 Feb 15:266:116153. doi: 10.1016/j.ejmech.2024.116153. Epub 2024 Jan 20.

Abstract

Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder that affects social skills, language, communication, and behavioral skills, significantly impacting the individual's quality of life. Recently, numerous works have centered on the connections between the immune and central nervous systems and the influence of neuroinflammation on autism symptomatology. Marine natural products are considered as important alternative sources of different types of compounds, including polysaccharides, polyphenols, sterols, carotenoids, terpenoids and, alkaloids. These compounds present anti-inflammatory, neuroprotective and immunomodulatory activities, exhibiting a potential for the treatment of many diseases. Although many studies address the marine compounds in the modulation of inflammatory mediators, there is a gap regarding their use in the regulation of the immune system in ASD. Thus, this review aims to provide a better understanding regarding cytokines, chemokines, growth factors and immune responses in ASD, as well as the potential of bioactive marine compounds in the immune regulation in ASD. We expect that this review would contribute to the development of therapeutic alternatives for controlling immune mediators and inflammation in ASD.

Keywords: ASD; Immune dysfunction; Inflammatory mediators; Neuroinflammation; Sea products.

Publication types

  • Review

MeSH terms

  • Autism Spectrum Disorder* / drug therapy
  • Cytokines
  • Humans
  • Immune System
  • Immunologic Factors
  • Inflammation / drug therapy
  • Quality of Life

Substances

  • Cytokines
  • Immunologic Factors